Tests a procedure video before eye injections for retinal disease patients
Tests whether watching a video before eye injections eases worry in adults with retinal disease.
Plain-language title generated from the registry record
Registry title: Effect of Video Viewing on Intravitreal Injection Experience
Key facts
- Where
- Hangzhou, ChinaSee the site
Where in China
- Second Affiliated Hospital, School of Medicine, Zhejiang UniversityHangzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Trial code
- NCT07002372
- Record updated
- 3 June 2025
- Original description
Study Objective The goal of this clinical trial is to evaluate whether viewing a procedural video can improve the patient experience and reduce the incidence and severity of subconjunctival hemorrhage in individuals undergoing intravitreal anti-VEGF injections.Read full original descriptionShow less
Impact of Procedural Video Viewing on Patients Undergoing Intravitreal Anti-VEGF Injections
Study Objective The goal of this clinical trial is to evaluate whether viewing a procedural video can improve the patient experience and reduce the incidence and severity of subconjunctival hemorrhage in individuals undergoing intravitreal anti-VEGF injections.
Key Research Questions
1. Can viewing the procedural video prior to treatment reduce the rate and/or area of subconjunctival hemorrhage? 2. Can the video improve the patient experience, specifically by reducing anxiety levels and increasing satisfaction with the treatment process?
Study Design Participants will be randomly assigned to either an intervention group, who will watch an educational video explaining the injection procedure, or a control group, who will not view the video.
All participants will complete the State-Trait Anxiety Inventory-State (STAI-S) questionnaire both before and after treatment to assess changes in anxiety levels.
Inclusion: Patients who are receiving their first intravitreal injection of anti-VEGF medication due to retinal diseases; Mentally competent, and able to communicate without barriers; Willing to voluntarily sign an informed consent form.
Exclusion: History of previous eye surgery; Best-corrected visual acuity in the better eye worse than 0.3; The target eye is complicated with neovascular glaucoma.